Merck KGaA (MKGAF)
164.00
+0.55
(+0.34%)
USD |
OTCM |
Aug 25, 16:00
Merck Shareholders Equity (Quarterly) : 34.50B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.50B |
| March 31, 2026 | 34.27B |
| December 31, 2025 | 33.58B |
| September 30, 2025 | 34.00B |
| June 30, 2025 | 33.17B |
| March 31, 2025 | 32.21B |
| December 31, 2024 | 30.98B |
| September 30, 2024 | 31.61B |
| June 30, 2024 | 30.60B |
| March 31, 2024 | 30.24B |
| December 31, 2023 | 29.47B |
| September 30, 2023 | 29.88B |
| June 30, 2023 | 29.13B |
| March 31, 2023 | 28.41B |
| December 31, 2022 | 27.67B |
| September 30, 2022 | 27.68B |
| June 30, 2022 | 27.13B |
| March 31, 2022 | 25.50B |
| December 31, 2021 | 24.27B |
| September 30, 2021 | 23.88B |
| June 30, 2021 | 22.88B |
| March 31, 2021 | 22.23B |
| December 31, 2020 | 20.73B |
| September 30, 2020 | 21.02B |
| June 30, 2020 | 20.20B |
| Date | Value |
|---|---|
| March 31, 2020 | 20.36B |
| December 31, 2019 | 20.05B |
| September 30, 2019 | 19.80B |
| June 30, 2019 | 19.99B |
| March 31, 2019 | 19.81B |
| December 31, 2018 | 19.66B |
| September 30, 2018 | 17.75B |
| June 30, 2018 | 17.32B |
| March 31, 2018 | 17.27B |
| December 31, 2017 | 16.81B |
| September 30, 2017 | 16.23B |
| June 30, 2017 | 15.63B |
| March 31, 2017 | 15.42B |
| December 31, 2016 | 14.75B |
| September 30, 2016 | 14.52B |
| June 30, 2016 | 14.21B |
| March 31, 2016 | 14.24B |
| December 31, 2015 | 13.89B |
| September 30, 2015 | 15.58B |
| June 30, 2015 | 15.42B |
| March 31, 2015 | 14.77B |
| December 31, 2014 | 14.21B |
| September 30, 2014 | 14.82B |
| June 30, 2014 | 15.28B |
| March 31, 2014 | 15.42B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| STRATEC SE | 272.61M |
| Sartorius AG | 3.227B |
| Petros Pharmaceuticals, Inc. | 0.7009M |
| Danaher Corp. | 52.58B |
| Illumina, Inc. | 2.838B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.24B |
| Total Liabilities (Quarterly) | 25.61B |
| Debt to Equity Ratio | 0.4077 |
| Current Ratio | 1.695 |
| Net Debt Paydown Yield | -1.26% |